These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts]. Lenzenhuber E; Müller C; Rommelspacher H; Spies C Anaesthesist; 1999 Feb; 48(2):89-96. PubMed ID: 10093649 [TBL] [Abstract][Full Text] [Related]
5. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990 [TBL] [Abstract][Full Text] [Related]
6. Prophylaxis of alcohol withdrawal syndrome in alcohol-dependent patients admitted to the intensive care unit after tumour resection. Spies CD; Dubisz N; Funk W; Blum S; Müller C; Rommelspacher H; Brummer G; Specht M; Hannemann L; Striebel HW Br J Anaesth; 1995 Dec; 75(6):734-9. PubMed ID: 8672322 [TBL] [Abstract][Full Text] [Related]
7. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Spies CD; Dubisz N; Neumann T; Blum S; Müller C; Rommelspacher H; Brummer G; Specht M; Sanft C; Hannemann L; Striebel HW; Schaffartzik W Crit Care Med; 1996 Mar; 24(3):414-22. PubMed ID: 8625628 [TBL] [Abstract][Full Text] [Related]
8. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study. Elsing C; Stremmel W; Grenda U; Herrmann T Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303 [TBL] [Abstract][Full Text] [Related]
9. Excretion of beta-carbolines harman and norharman in 24-hour urine of chronic alcoholics during withdrawal and controlled abstinence. Wodarz N; Wiesbeck GA; Rommelspacher H; Riederer P; Böning J Alcohol Clin Exp Res; 1996 Jun; 20(4):706-10. PubMed ID: 8800388 [TBL] [Abstract][Full Text] [Related]
10. Alcohol withdrawal severity is decreased by symptom-orientated adjusted bolus therapy in the ICU. Spies CD; Otter HE; Hüske B; Sinha P; Neumann T; Rettig J; Lenzenhuber E; Kox WJ; Sellers EM Intensive Care Med; 2003 Dec; 29(12):2230-2238. PubMed ID: 14557857 [TBL] [Abstract][Full Text] [Related]
11. Prevention and therapy of alcohol withdrawal on intensive care units: systematic review of controlled trials. Ungur LA; Neuner B; John S; Wernecke K; Spies C Alcohol Clin Exp Res; 2013 Apr; 37(4):675-86. PubMed ID: 23550610 [TBL] [Abstract][Full Text] [Related]
12. Blood alcohol concentration for monitoring ethanol treatment to prevent alcohol withdrawal in the intensive care unit. Eggers V; Tio J; Neumann T; Pragst F; Müller C; Schmidt LG; Kox WJ; Spies CD Intensive Care Med; 2002 Oct; 28(10):1475-82. PubMed ID: 12373474 [TBL] [Abstract][Full Text] [Related]
13. Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit? Steel TL; Giovanni SP; Katsandres SC; Cohen SM; Stephenson KB; Murray B; Sobeck H; Hough CL; Bradley KA; Williams EC Addict Sci Clin Pract; 2021 Mar; 16(1):21. PubMed ID: 33762020 [TBL] [Abstract][Full Text] [Related]
15. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar. Pittman B; Gueorguieva R; Krupitsky E; Rudenko AA; Flannery BA; Krystal JH Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040 [TBL] [Abstract][Full Text] [Related]
16. Implementation of a CIWA-Ar alcohol withdrawal protocol in a veterans hospital. Waye C; Wong M; Lee S South Med J; 2015 Jan; 108(1):23-8. PubMed ID: 25580753 [TBL] [Abstract][Full Text] [Related]
17. Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome. Maldonado JR; Sher Y; Das S; Hills-Evans K; Frenklach A; Lolak S; Talley R; Neri E Alcohol Alcohol; 2015 Sep; 50(5):509-18. PubMed ID: 25999438 [TBL] [Abstract][Full Text] [Related]
18. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome. Nuss MA; Elnicki DM; Dunsworth TS; Makela EH W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493 [TBL] [Abstract][Full Text] [Related]
19. Exposure to beta-carbolines norharman and harman. Pfau W; Skog K J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Mar; 802(1):115-26. PubMed ID: 15036003 [TBL] [Abstract][Full Text] [Related]
20. Harman and norharman in alcoholism: correlations with psychopathology and long-term changes. Rommelspacher H; Dufeu P; Schmidt LG Alcohol Clin Exp Res; 1996 Feb; 20(1):3-8. PubMed ID: 8651457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]